When was Converge Bio's last funding round?

Converge Bio's most recent recorded round was Early Stage VC (Series A) in Jan 2026, raising $25.0M.

PrivateMarketView

How much has Converge Bio raised?

$30.5Macross 1 recorded rounds · Jan 2026 – Jan 2026

Most recently, Converge Bio raised $25.0M in its Early Stage VC (Series A) (Jan 2026).

Free account

More of Converge Bio with a free account

No card required

Membership and data by Private Market View

1 rounds

Jan 2026Early Stage VC (Series A)$25.0M▮

+ 1 more investors · free account

Converge Bio has raised $30.5 million across 1 recorded round since 2026. The largest was a $25 million Series A in Jan 2026.

Converge Bio has filed 1 Form D with the SEC, most recently in Apr 2026 ($25 million sold to 19 investors).

6 investors are on record for Converge Bio, including Bessemer Venture Partners, AWS Startups, TLV Partners and Vintage (Private Equity). The Series A in Jan 2026 drew 2 investors.

For fundraisers

Raising for a company like Converge Bio?

6 investors have backed Converge Bio — start your target list with the firms already writing checks in other information technology.

How much has Converge Bio raised?: Converge Bio has raised $30.5M in total across 1 recorded funding rounds.
When was Converge Bio's last funding round?: Converge Bio's most recent recorded round was Early Stage VC (Series A) in Jan 2026, raising $25.0M.